Global DNA hypomethylation-induced ΔNp73 transcriptional activation in non-small cell lung cancer.
暂无分享,去创建一个
John K Field | Stella Logotheti | Anastasia N Kastania | V. Zoumpourlis | T. Liloglou | J. Field | J. Gosney | George Xinarianos | Triantafillos Liloglou | A. Kastania | G. Xinarianos | S. Markopoulou | Vassilis Zoumpourlis | Alexandros Daskalos | Soultana Markopoulou | John R Gosney | Stella Logotheti | A. Daskalos
[1] B. Pützer,et al. Transactivation-deficient ΔTA-p73 Acts as an Oncogene , 2002 .
[2] D. Spandidos,et al. Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73γ in lung cancer , 2010, The FEBS journal.
[3] J. Benítez,et al. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non‐Hodgkin's lymphomas , 2002, International journal of cancer.
[4] S. Ferrini,et al. Role of methylation in the control of ΔNp73 expression in neuroblastoma , 2002, Cell Death and Differentiation.
[5] Luyang Sun,et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis , 2005, Nature.
[6] S. Inoue,et al. Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. , 2010, Genes & development.
[7] F. McKeon,et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. , 2000, Science.
[8] B. Joseph,et al. The role of p73 in hematological malignancies , 2006, Leukemia.
[9] M. Caligiuri,et al. Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.
[10] B. Pützer,et al. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. , 2002, Journal of Biological Chemistry.
[11] I. Casciano,et al. Methylation-independent silencing of the p73 gene in neuroblastoma , 2000, Oncogene.
[12] Christian B. Woods,et al. Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.
[13] G. Melino,et al. Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53 , 2001, Cell Death and Differentiation.
[14] Zhong-ying Shen,et al. NGALR Is Overexpressed and Regulated by Hypomethylation in Esophageal Squamous Cell Carcinoma , 2008, Clinical Cancer Research.
[15] Apiwat Mutirangura,et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis , 2004, Oncogene.
[16] Keara M. Lane,et al. Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas. , 2009, Cancer research.
[17] M. Morita,et al. Expression of ΔNp73 Predicts Poor Prognosis in Lung Cancer , 2004, Clinical Cancer Research.
[18] R. Shaw,et al. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing , 2006, Nucleic acids research.
[19] T. Oyama,et al. Expression of the p53 family in lung cancer. , 2006, Anticancer research.
[20] A. Loriot,et al. DNA hypomethylation in cancer: Epigenetic scars of a neoplastic journey , 2010, Epigenetics.
[21] J. Herman,et al. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours , 2002, The Journal of pathology.
[22] U. Moll,et al. p63 and p73: roles in development and tumor formation. , 2004, Molecular cancer research : MCR.
[23] Y. Kwong,et al. Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved. , 2002, The American journal of pathology.
[24] A. Cassidy,et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non‐small cell lung cancer , 2009, International journal of cancer.
[25] J. Herman,et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. , 1999, Cancer research.
[26] Andrea Tannapfel,et al. Quantitative TP73 Transcript Analysis in Hepatocellular Carcinomas , 2004, Clinical Cancer Research.
[27] G. Watanabe,et al. Long Interspersed Nuclear Element 1 Hypomethylation Is a Marker of Poor Prognosis in Stage IA Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.
[28] C. Brigati,et al. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer. , 2009, International Journal of Oncology.